The relationship between miRNA-26b and connective tissue growth factor in rat models of aortic banding and debanding
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Connective tissue growth factor (CTGF) is a profibrotic factor implicated in pressure overload-mediated myocardial fibrosis. In this study, we determined the role of predicted CTGF-targeting microRNAs (miRNAs) in rat models of aortic stenosis and reverse cardiac remodeling. Methods: Minimally invasive ascending aortic banding was performed in 24 7-week-old male Sprague-Dawley rats, which were divided into three groups. The banding group consisted of eight rats that were sacrificed immediately after 6 weeks of aortic constriction. The debanding group underwent aortic constriction for 4 weeks and was sacrificed 2 weeks after band removal. The third group underwent sham surgery. We investigated the expression of CTGF, transforming growth factor-β1 (TGFβ1), and matrix metalloproteinase-2 using ELISA and examined miRNA-26b, miRNA-133a, and miRNA-19b as predicted CTGF-targeting miRNAs based on miRNA databases in 24-hour TGFβ-stimulated and TGFβ- washed fibroblasts and myocardial tissues from all subjects. Results: CTGF was elevated in 24-hour TGFβ-stimulated fibroblasts and decreased in 24-hour TGFβ-washed fibroblasts. miRNA-26b was significantly increased in TGFβ-washed fibroblasts compared with control and TGFβ-stimulated fibroblasts (p < 0.05). CTGF expression was significantly higher in the banding group than that in the sham and debanding groups. The relative expression levels of miRNA-26b were higher in the debanding group than in the banding group. Conclusions: The results of our study using models of aortic banding and debanding suggested that miRNA-26b was significantly increased after aortic debanding. The in vitro model yielded the same results: miRNA-26b was upregulated after removal of TGFβ from fibroblasts.
Abstract
Background/Aims: Connective tissue growth factor (CTGF) is a profibrotic factor implicated in pressure overload-mediated myocardial fibrosis. In this study, we determined the role of predicted CTGF-targeting microRNAs (miRNAs) in rat models of aortic stenosis and reverse cardiac remodeling. Methods: Minimally invasive ascending aortic banding was performed in 24 7-week-old male Sprague-Dawley rats, which were divided into three groups. The banding group consisted of eight rats that were sacrificed immediately after 6 weeks of aortic constriction. The debanding group underwent aortic constriction for 4 weeks and was sacrificed 2 weeks after band removal. The third group underwent sham surgery. We investigated the expression of CTGF, transforming growth factor-β1 (TGFβ1), and matrix metalloproteinase-2 using ELISA and examined miRNA-26b, miRNA-133a, and miRNA-19b as predicted CTGF-targeting miRNAs based on miRNA databases in 24-hour TGFβ-stimulated and TGFβ- washed fibroblasts and myocardial tissues from all subjects. Results: CTGF was elevated in 24-hour TGFβ-stimulated fibroblasts and decreased in 24-hour TGFβ-washed fibroblasts. miRNA-26b was significantly increased in TGFβ-washed fibroblasts compared with control and TGFβ-stimulated fibroblasts (p < 0.05). CTGF expression was significantly higher in the banding group than that in the sham and debanding groups. The relative expression levels of miRNA-26b were higher in the debanding group than in the banding group. Conclusions: The results of our study using models of aortic banding and debanding suggested that miRNA-26b was significantly increased after aortic debanding. The in vitro model yielded the same results: miRNA-26b was upregulated after removal of TGFβ from fibroblasts.
참고문헌 (27)
- Houser SR, "Animal models of heart failure : a scientific statement from the American Heart Association", Circ Res, 111, pp.131~150 (2012)
- Bjornstad JL, "A mouse model of reverse cardiac remodelling following banding-debanding of the ascending aorta", Acta Physiol(Oxf), 205, pp.92~102 (2012)
- 조정선, "Myocardial Mechanics in a Rat Model with Banding and Debanding of the Ascending Aorta", Journal of Cardiovascular Imaging, 22(4), pp.189~195 (2014), 한국심초음파학회[DOI]
- Gao XM, "Regression of pressure overload-induced left ventricular hypertrophy in mice", Am J Physiol Heart Circ Physiol, 288, pp.H2702~H2707 (2005)
- Weber KT, "Myofibroblast-mediated mechanisms of pathological remodelling of the heart", Nat Rev Cardiol, 10, pp.15~26 (2013)
- Kakkar R, "Intramyocardial fibroblast myocyte communication", Circ Res, 106, pp.47~57 (2010)
- Howard CM, "Dynamic cell-cell and cell-ECM interactions in the heart", J Mol Cell Cardiol, 70, pp.19~26 (2014)
- Dendooven A, "Connective tissue growth factor(CTGF", CCN2)ELISA : a novel tool for monitoring fibrosis, 2011, pp.16, 289~301
- Lipson KE, "CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis", Fibrogenesis Tissue Repair, 5(Suppl 1), pp.S24~ (2012)
- Mori T, "Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis : a mouse fibrosis model", J Cell Physiol, 181, pp.153~159 (1999)
- Szabo Z, "Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure", Hypertension, 63, pp.1235~1240 (2014)
- Bauer M, "Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice", Circ Res, 108, pp.908~916 (2011)
- Gao S, "Echocardiography in mice", Curr Protoc Mouse Biol, 1, pp.71~83 (2011)
- Derumeaux G, "Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats", Circulation, 105, pp.1602~1608 (2002)
- Kovacs A, "Strain and strain rate by speckle-tracking echocardiography correlate with pressure-volume loop-derived contractility indices in a rat model of athlete’s heart", Am J Physiol Heart Circ Physiol, 308, pp.H743~H748 (2015)
- Wang G, "Effects of anesthesia on conventional and speckle tracking echocardiographic parameters in a mouse model of pressure overload", Exp Ther Med, 9, pp.1679~1687 (2015)
- Friedman RC, "Most mammalian mRNAs are conserved targets of microRNAs", Genome Res, 19, pp.92~105 (2009)
- Yokoi H, "Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis", J Am Soc Nephrol, 15, pp.1430~1440 (2004)
- Duisters RF, "miR-133 and miR30 regulate connective tissue growth factor : implications for a role of microRNAs in myocardial matrix remodeling", Circ Res, 104, pp.170~178 (2009)
- Gao S, "Downregulation of microRNA-19b contributes to angiotensin II-induced overexpression of connective tissue growth factor in cardiomyocytes", Cardiology, 127, pp.114~120 (2014)
- Guo Y, "Downregulation of miR-18a induces CTGF and promotes proliferation and migration of sodium hyaluronate treated human corneal epithelial cells", Gene, 591, pp.129~136 (2016)
- van Almen GC, "MicroRNA-18 and microRNA-19 regulate CTGF and TSP1 expression in age-related heart failure", Aging Cell, 10, pp.769~779 (2011)
- Martello A, "Phenotypic miRNA screen identifies miR-26b to promote the growth and survival of endothelial cells", Mol Ther Nucleic Acids, 13, pp.29~43 (2018)
- Zhu Y, "MicroRNA-26a", b and their host genes cooperate to inhibit the G1, Nucleic Acids Res, pp.2012, 40[DOI]
- Sapkota G, "Dephosphorylation of the linker regions of Smad1 and Smad2", 3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways, 2006, pp.281, 40412~40419
- Wang R, "Microrna-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor(CTGF)and cyclin D1(CCND1)", Oncotarget, 7, pp.72746~72757 (2016)
- Beaumont J, "MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure", Sci Rep, 7, pp.40696~ (2017)